Clinical studies have also shown that dysregulation of the expression of JAK1 and JAK2 associates with brain inflammatory processes and neuronal or glial survival, which are consequently involved in most brain disorders including the pathogenesis of AD [33]. Here, JAK1 is linked to Alzheimer disease.